QuVa Pharma Completes $275 Million Financing with Syndicate Led by Goldman Sachs

QuVa Pharma Completes $275 Million Financing with Syndicate Led by Goldman Sachs
Following Multiple Years of Strong Growth, Financing Further Validates 503B Industry Value Proposition, Demonstrates Strength of QuVa Pharma and Attractiveness of Ongoing Business Growth Initiatives
News provided by
Share this article
Share this article
SUGAR LAND, Texas, May 6, 2021 /PRNewswire/ -- QuVa Pharma, Inc.("QuVa Pharma"), the leading national 503B outsourcing services company providing hospitals with essential medications in ready-to-administer injectable formats, today announced its latest financing, a $275 million senior debt facility led by investment vehicles managed by the Goldman Sachs Private Credit Investing("Goldman Sachs"), with participation from Owl Rock Capital Partners, LP ("Owl Rock"). The financing enables QuVa Pharma to meet the needs of its approximately 2,000 hospital customers, add more hospitals to the platform, and expand its 200 SKU product portfolio.

Related Keywords

Texas ,United States ,New Jersey ,Stuart Hinchen ,Quva Pharma ,Andrew Kaplan ,Goldman Sachs ,Alex Chi ,Quva Pharma Inc ,Prnewswire Quva Pharma Inc ,Quva Pharma Customer Service ,Latham Watkins ,Ropes Gray ,Goldman Sachs Private Credit Investing ,Owl Rock Capital Partners ,Owl Rock ,Chief Executive ,Bain Capital Private ,Americas Private Credit Investing ,டெக்சாஸ் ,ஒன்றுபட்டது மாநிலங்களில் ,புதியது ஜெர்சி ,ஸ்டூவர்ட் ஹின்செங் ,ஆண்ட்ரூ கபிலன் ,கோல்ட்மேன் சாக்ஸ் ,லாதம் வாட்கின்ஸ் ,கயிறுகள் சாம்பல் ,ஔல் பாறை மூலதனம் கூட்டாளர்கள் ,ஔல் பாறை ,தலைமை நிர்வாகி ,பைன் மூலதனம் ப்ரைவேட் ,